DaVita Inc. (NYSE:DVA) China affiliate agreed to invest CNY 147 million ($22.87 million) in Hunan Fangsheng Pharmaceutical Co., Ltd. (SHSE:603998)'s unit for 31.7% stake. says it plans to buy pharma firm for up to CNY 185.8 million.